| Patent title | Granted | Pending | |
| Taiwan | 后生元提取物的制备方法以及由该方法所得到的产物及其用于抑制生物膜形成与促进肠道健康之用途。 A method for preparing postbiotic extract, and its products obtained therefrom for inhibiting biofilm formation and promoting intestinal health. |
TW I733446 | |
| 后生元提取物用于预防和/或治疗关节炎与关节退化的用途。 The use of postbiotic extract for the prevention and/or treatment of arthritis and joint degeneration. |
TW I739424 | ||
| 后生元提取物用于促进皮肤再生与抗老化的用途。 The use of postbiotic extract for promoting skin regeneration and anti-aging. |
TW I748448 | ||
| 具有核壳结构的益生菌颗粒。 Probiotic particles with nuclear-shell structure. |
TW M602905U | ||
| 使用热致死的乳酸菌菌株来治疗和/或预防微粒物质-诱发的肺损伤。 The use of heat-killed Lactobacillus strains for treating and/or preventing particulate matter-induced lung injury. |
TW I802009 | ||
| 使用一包含有植物乳杆菌 CB102 分离株与燕窝酸的组合来改善皮肤病况。 The use of a combination comprising a plant-derived Lactobacillus CB102 isolate and hyaluronic acid for improving skin conditions. |
TW I808582 | ||
| 益生菌与后生元的组合在改善 SARS-CoV-2 感染相关的病况上的用途。 Method of using a combination of postbiotics and probiotics for prevention of severe acute respiratory syndrome coronavirus 2 infection-associated disorders. |
112120383 | ||
| 具稳定包覆活性成分能力之复合结构保健品。 A composite structural health supplement with the ability for stable encapsulation of active ingredients. |
112212381 | ||
| China | 后生元提取物的制法以及该方法得到的产物及其抑制生物膜形成与促进肠道健康的用途。 The method of preparing postbiotic extract, the product obtained by the method, and its use for inhibiting biofilm formation and promoting intestinal health. |
202010601125.5 | |
| 后生元提取物用于预防和/或治疗关节炎与关节退化的用途。 The use of postbiotic extract for the prevention and/or treatment of arthritis and joint degeneration. |
202010601311.9 | ||
| 后生元提取物用于促进皮肤再生与抗老化的用途。 The use of postbiotic extract for promoting skin regeneration and anti-aging. |
202010601261.4 | ||
| 具有核壳结构的益生菌颗粒及益生菌软胶囊。 Probiotic particles with nuclear-shell structure and probiotic soft capsules. |
CN 213549547U | ||
| 热致死的乳酸菌菌株作为制备治疗和/或预防微粒物质-诱发的肺损伤的医药品的用途。 The use of heat-killed Lactobacillus strains as a pharmaceutical preparation for the treatment and/or prevention of particulate matter-induced lung injury. |
202111291686.0 | ||
| 包含植物乳杆菌 CB102 与燕窝酸的组合在制备用来改善皮肤病况的组合物中的用途。 The use of a combination comprising a plant-derived Lactobacillus CB102 isolate and hyaluronic acid in the preparation of a composition for improving skin conditions. |
202211396626.X | ||
| 益生菌与后生元的组合在改善 SARS-CoV-2 感染相关的病况上的用途。 Method of using a combination of postbiotics and probiotics for prevention of severe acute respiratory syndrome coronavirus 2 infection-associated disorders. |
202310870474.0 | ||
| 具有稳定包覆活性成分能力之复合结构保健品。 A composite structural health supplement with the ability for stable encapsulation of active ingredients. |
202323294033.5 | ||
| USA | POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF | US 11541085 B2 | |
| METHOD FOR ALLEVIATING ARTHRITIS WITH POSTBIOTIC EXTRACT | US 11517596 B2 | ||
| METHOD FOR IMPROVING SKIN CONDITION WITH POSTBIOTIC EXTRACT | US 11517597 B2 | ||
| METHOD FOR PREVENTING OR ALLEVIATING PARTICULATE MATTER-INDUCED LUNG INJURY | 17/529474 | ||
| POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF "splitting case" (inhibiting biofilm formation) | 18/051968 | ||
| POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF "Splitting case" (promoting intestinal health) | 18/051983 | ||
| METHOD OF USING A COMBINATION OF POSTBIOTICS AND PROBIOTICS FOR PREVENTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION-ASSOCIATED DISORDERS. | 18/499450 |
| Year | Papers title | Journal / Exhibition name |
| 2023 | 后生元协同益生菌减轻由 PM2.5 引起的肺损伤及过敏。 Synergistic effect of probiotic and postbiotic on attenuation of PM2.5-induced lung damage and allergic response. |
J Food Sci. 2023;88(1):513-522. doi:10.1111/1750-3841.16398 |
| 久司酵素增强版透过纤维与体内油脂结合与促进排出来改善肠道健康。 BraziZyme® PLUS improves gastrointestinal health through its fiber-mediated binding and excretion of intracellular lipids . |
2023 台湾乳酸菌协会研讨会。 2023 Taiwan Association for Lactic Acid Bacteria Conference. |
